Multiple system atrophy (MSA) is a rare disorder with limited treatment options. However, recent research has yielded potential developments into new therapeutic approaches. Current focus centers on addressing the underlying causes of MSA. One approach under investigation involves therapeutic interventions to influence the dysregulation of specifi